 RADNOR, Pa., Aug. 19, 2021 PRNewswire -- NRx Pharmaceuticals NRx Nasdaq: NRXP or the Company, a Delaware corporation, today announced that it has entered into definitive agreements with investors to purchase 2,727,273 shares of common stock in a private placement. 